What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Disease
His main research concerns Diabetes mellitus, Internal medicine, Endocrinology, Type 2 diabetes and Gerontology.
Richard F. Hamman has included themes like Body mass index, Randomized controlled trial, Incidence and Weight loss in his Diabetes mellitus study.
His work deals with themes such as Metformin, Diabetes risk and Hazard ratio, which intersect with Randomized controlled trial.
His work focuses on many connections between Type 2 diabetes and other disciplines, such as Pregnancy, that overlap with his field of interest in Childhood obesity.
His Gerontology research integrates issues from Diabetic retinopathy, Hispanic ethnicity, Research design, Prevalence and Depression.
His Impaired glucose tolerance research incorporates themes from Odds ratio and Confidence interval.
His most cited work include:
- Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (14249 citations)
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy (2033 citations)
- 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. (1957 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Diabetes mellitus, Internal medicine, Endocrinology, Type 2 diabetes and Gerontology.
His work in Diabetes mellitus tackles topics such as Confidence interval which are related to areas like Odds ratio.
His research in Body mass index, Insulin, Risk factor, Insulin resistance and Impaired glucose tolerance are components of Internal medicine.
Type 2 diabetes is closely attributed to Metformin in his work.
His work carried out in the field of Metformin brings together such families of science as Placebo, Weight loss and Diabetes risk.
His Gerontology research is multidisciplinary, incorporating perspectives in Research design, Randomized controlled trial, Epidemiology and Psychological intervention.
He most often published in these fields:
- Diabetes mellitus (56.70%)
- Internal medicine (51.57%)
- Endocrinology (32.19%)
What were the highlights of his more recent work (between 2011-2021)?
- Diabetes mellitus (56.70%)
- Internal medicine (51.57%)
- Type 1 diabetes (16.81%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Diabetes mellitus, Internal medicine, Type 1 diabetes, Type 2 diabetes and Endocrinology.
The various areas that Richard F. Hamman examines in his Diabetes mellitus study include Research design, Disease, Pediatrics and Risk factor.
In his work, Odds ratio is strongly intertwined with Surgery, which is a subfield of Internal medicine.
His Type 2 diabetes study combines topics in areas such as Observational study, Incidence, Gerontology, Epidemiology and Medical record.
The concepts of his Endocrinology study are interwoven with issues in Allele and Confidence interval.
His study looks at the relationship between Metformin and fields such as Diabetes risk, as well as how they intersect with chemical problems.
Between 2011 and 2021, his most popular works were:
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy (2033 citations)
- Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009 (819 citations)
- The SEARCH for Diabetes in Youth study: rationale, findings, and future directions. (391 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Disease
The scientist’s investigation covers issues in Diabetes mellitus, Internal medicine, Type 1 diabetes, Type 2 diabetes and Endocrinology.
His Diabetes mellitus study combines topics from a wide range of disciplines, such as Research design, Intensive care medicine, Positive predicative value, Diagnosis code and Etiology.
His research in Internal medicine intersects with topics in Physical therapy and Birth weight.
His study in Type 1 diabetes is interdisciplinary in nature, drawing from both Body mass index, Cardiology, Young adult, Arterial stiffness and Disease.
His biological study spans a wide range of topics, including Odds ratio, Incidence, Cohort study, Gerontology and Type 2 Diabetes Mellitus.
As a part of the same scientific family, he mostly works in the field of Metformin, focusing on Diabetes risk and, on occasion, Genetic risk, Intervention and Placebo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
